1979
DOI: 10.1001/archopht.1979.01020010495025
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Phenylephrine on the Cornea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
1

Year Published

1980
1980
2013
2013

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(15 citation statements)
references
References 10 publications
2
12
1
Order By: Relevance
“…In 1990 [11], following the description of the dramatic effect of XYL/KET on the aqueous concentration of glucose [12], the opacification of the lens was recognized as a typical sugar cataract [13,14], suggesting that an osmotic mechanism could also be responsible for corneal decompensation and transient loss of transparency. However, other mechanistic hypotheses cannot be ruled out, including the perturbation of the adrenergic control of corneal hydration and transparency [15][16][17][18] as indicated by the known corneal toxicity of other ·-agonists [19][20][21][22][23]. Corneal toxic effects of clonidine (CLO), another selective · 2 -adrenergic agonist, have been described in the rat [24], but not in humans, despite its wide use as a systemic hypotensive drug and anesthetic adjuvant [25][26][27].…”
Section: Introductionsupporting
confidence: 39%
“…In 1990 [11], following the description of the dramatic effect of XYL/KET on the aqueous concentration of glucose [12], the opacification of the lens was recognized as a typical sugar cataract [13,14], suggesting that an osmotic mechanism could also be responsible for corneal decompensation and transient loss of transparency. However, other mechanistic hypotheses cannot be ruled out, including the perturbation of the adrenergic control of corneal hydration and transparency [15][16][17][18] as indicated by the known corneal toxicity of other ·-agonists [19][20][21][22][23]. Corneal toxic effects of clonidine (CLO), another selective · 2 -adrenergic agonist, have been described in the rat [24], but not in humans, despite its wide use as a systemic hypotensive drug and anesthetic adjuvant [25][26][27].…”
Section: Introductionsupporting
confidence: 39%
“…No clinical signs of corneal edema were reported, but unfortunately the density of endothelial cell was not evaluated. In an early report by Edelhauser et al, a cytotoxic effect on the endothelium of phenylephrine at a concentration of 2.5% was described in cases where the epithelium was removed (Edelhauser et al 1979). In a recent report on corneal endothelial cell changes in cataract patients on tamsulosin we found no association between the intracameral use of 0.25 mL phenylephrine 2.5% (Minims®) in 2 mL BBS and postoperative endothelial cell loss (Storr-Paulsen et al 2013).…”
Section: Intracameral Injection Of Phenylephrinecontrasting
confidence: 40%
“…In addition, we showed that significant corneal edema, as well as stromal and endothelial cell vacuolization, is produced in rabbits by topi cally applied solutions of PE as dilute as 2.5 % if the epithelium is denuded before drug application [1,3]. The present study was designed to examine the direct effects of known PE concentrations on monolayers of bovine corneal endothelial cells maintained in tissue culture.…”
Section: Introductionsupporting
confidence: 41%
“…Phase contrast microscopy and SEM have shown that confluent monolayer cultures of bovine corneal endothelium are very similar to the endothelial layers found in situ on the corneas of rabbits [3] and cats [1]. Incubation of corneal endothelial cell cultures with PE caused uptake of drug into cytoplasmic vacuoles, accompanied by the loss of intercellular adhesion.…”
Section: Discussionmentioning
confidence: 41%
See 1 more Smart Citation